DS20362725
Modify Date: 2024-09-16 19:32:51
DS20362725 structure
|
Common Name | DS20362725 | ||
|---|---|---|---|---|
| CAS Number | 2735803-20-8 | Molecular Weight | 310.39 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H22N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DS20362725DS20362725 is an estrogen-related receptor α (ERRα) agonist. DS20362725 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM) with an >IC50 value of 0.6 μM. DS20362725 can be used for the research of metabolic disorders, including type 2 diabetes mellitus (T2DM)[1]. |
| Name | DS20362725 |
|---|
| Description | DS20362725 is an estrogen-related receptor α (ERRα) agonist. DS20362725 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM) with an >IC50 value of 0.6 μM. DS20362725 can be used for the research of metabolic disorders, including type 2 diabetes mellitus (T2DM)[1]. |
|---|---|
| Related Catalog | |
| Target |
ERRα |
| In Vitro | DS20362725 (0.002, 0.006, 0.017, 0.051, 0.015, 0.046, 1.4, 4.2, 12.5 μg/mL; 18 h) inhibits the transcriptional activity of full-length ERRα in MG63 cells with an EC50 of 1.1 μM[1]. |
| References |
| Molecular Formula | C19H22N2O2 |
|---|---|
| Molecular Weight | 310.39 |